1-4 of 4
Milan Matuska
Close
Sort by
Journal Articles

Impact Of Rituximab Maintenance Schedule On Prognosis In First Line Treatment Of Follicular Lymphoma. Retrospective Analysis From Czech Lymphoma Group (CLG) Database

Andrea Janikova, MD, PhD, Zbynek Bortlicek, Vit Campr, MD, Ph.D., Leos Kren, MD, PhD, David Belada, M.D., Ph.D., Vit Prochazka, M.D., Ph.D., Robert Pytlik, MD, Ph.D., Jan Pirnos, MD, Milan Matuska, MD, PhD, Tomas Papajik, MD, PhD, ass. prof., Heidi Mocikova, MD, PhD, Samuel Vokurka, MD, PhD, Jiri Mayer, MD, PhD, Marek Trneny, MD, Ph.D., Prof.
Journal: Blood
Blood (2013) 122 (21): 4387.
https://doi.org/10.1182/blood.V122.21.4387.4387
Published: 2013
Journal Articles

Radiotherapy With Rituximab Is Better than Radiotherapy alone In First Line Treatment Of Localized Follicular Lymphoma. Time To Change a Standard Strategy?

Andrea Janikova, MD, PhD, Katerina Benesova, MD, Zbynek Bortlicek, Vit Campr, MD, Ph.D., Natasa Kopalova, David Belada, M.D., Ph.D., Vit Prochazka, M.D., Ph.D., Robert Pytlik, MD, Ph.D., Samuel Vokurka, MD, PhD, Jan Pirnos, MD, Milan Matuska, MD, PhD, Heidi Mocikova, MD, PhD, Jiri Mayer, MD, PhD, Marek Trneny, MD, Ph.D., Prof.
Journal: Blood
Blood (2013) 122 (21): 4388.
https://doi.org/10.1182/blood.V122.21.4388.4388
Published: 2013
Journal Articles

Median Absolute Lymphocyte Count Independently Predicts Survival of Elderly Patients with Diffuse Large B-Cell Lymphoma Treated with R-Chemotherapy: Analysis of 651 Patients Included In the Czech Lymphoma Project

Vit Prochazka, Marek Trneny, David Salek, MD, David Belada, Tomas Kozak, Tomas Papajik, Robert Pytlik, Ingrid Vasova, MD, Alice Sykorova, Milada Jankovska, Katerina Kubackova, Martin Brejcha, MD, Milan Matuska, Katarina Petrakova, Jan Pirnos, J. Nepomucka, David Starostka, Milan Lysy, Vit Campr, Ludmila Boudova, Marie Trnkova, Marketa Petrova, on Behalf Of Czech Lymphoma Study Group
Journal: Blood
Blood (2010) 116 (21): 2882.
https://doi.org/10.1182/blood.V116.21.2882.2882
Published: 2010
Journal Articles

Treatment of Diffuse Large B-Cell Lymphoma with Rituximab, Intensive Induction and High-Dose Consolidation: The Final Analysis of the Czech Lymphoma Study Group (CLSG) R-MegaCHOP-ESHAP-BEAM (R-MEB) Trial.

Marek Trneny, Robert Pytlik, David Belada, Katerina Kubackova, Ingrid Vasova, Alice Sykorova, Tomas Kozak, Jan Pirnos, Milan Matuska, Ingrid Bolomska, Jana Pribylova, Marie Trnkova, Michaela Hamouzova, Pavel Klener
Journal: Blood
Blood (2007) 110 (11): 21.
https://doi.org/10.1182/blood.V110.11.21.21
Published: 2007